Leading offsite manufacturer McAvoy has appointed Andy Myers to the newly created role of Pharmaceutical Strategy Lead, as the business builds on its growing track record in the pharmaceutical and life sciences sectors.
With over 15 years of experience between the pharmaceutical and healthcare sectors, Andy brings extensive expertise in business development and client relationship management. He will support the next phase of McAvoy’s strategic growth in the sector, working with clients to deliver high-quality modular buildings for cleanrooms, laboratories, research centres, office spaces and science parks – whether for permanent facilities or temporary use.
Andy joins McAvoy following the company’s successful delivery of several projects in the sector, including the Collaborative Research and Innovation Centre at Porton Science Park.
Andy said: “Speed, efficiency, and sustainability are critical in the pharmaceutical sector, and McAvoy’s compelling turnkey design and build value proposition aligns well with the needs of this market. I’m looking forward to expanding the reach of the work we do at what is a crucial time, as demand for high-performance facilities continues to grow.”
Stephen Clayton, Preconstruction Director at McAvoy, said: “This appointment reflects our wider investment and expansion plans to bring more of our high-quality space solutions to the pharmaceutical and life sciences sectors. As demand for new facilities increases, we know modular construction will play an increasingly vital role.”